Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Other financing activities (2018 - 2024)

Catheter Precision (VTAK) has disclosed Other financing activities for 4 consecutive years, with $309000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Other financing activities changed N/A to $309000.0 in Q2 2024 year-over-year; TTM through Jun 2024 was $768000.0, a 44.36% increase, with the full-year FY2023 number at $640000.0, changed N/A from a year prior.
  • Other financing activities was $309000.0 for Q2 2024 at Catheter Precision, down from $640000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $872000.0 in Q3 2022 to a low of -$1.5 million in Q1 2022.
  • A 3-year average of -$31285.7 and a median of $181000.0 in 2023 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 111.92% in 2023; the steepest drop was 120.76% in 2023.
  • Catheter Precision's Other financing activities stood at $872000.0 in 2022, then fell by 26.61% to $640000.0 in 2023, then plummeted by 51.72% to $309000.0 in 2024.
  • Per Business Quant, the three most recent readings for VTAK's Other financing activities are $309000.0 (Q2 2024), $640000.0 (Q4 2023), and -$181000.0 (Q3 2023).